CHLAMYDIAL INFECTIONS AND THE QUINOLONES

被引：8

作者：

RONALD, AR

PEELING, RW

机构：

[1] Department of Medical Microbiology, University of Manitoba, Winnipeg, R3E OW3, Manitoba, Room 543

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1991年 / 10卷 / 04期

关键词：

D O I：

10.1007/BF01967010

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Some of the newer fluoroquinolones may be suitable agents for the treatment of Chlamydia trachomatis infections and non-gonococcal urethritis. To date, small studies with both ofloxacin and fleroxacin appear to achieve cure rates of 85-100% for urethritis and cervicitis due to Chlamydia trachomatis. However, large well-designed clinical trials are required to determine the efficacy and acceptance of these and other fluoroquinolones in the treatment of patients with genital or respiratory syndromes due to chlamydiae or other bacterial pathogens causing infections with similar manifestations.

引用

页码：351 / 354

页数：4

共 23 条

[1]

BATTEIGER BE, 1989, AM J MED S6C, V87, P75

[2] DOSE-RANGING STUDY OF FLEROXACIN FOR TREATMENT OF UNCOMPLICATED CHLAMYDIA-TRACHOMATIS GENITAL INFECTIONS [J].